Means, Arianna R., Dean, Laura ORCID: https://orcid.org/0000-0002-4910-9707, Ozano, Kim, Adekeye, Oluwatosin, Dixon, Ruth, Fung, Ebua Gallus, Gyapong, Margaret, Isiyaku, Sunday, Kollie, Karsor, Kukula, Vida, Lar, Luret, MacPherson, Eleanor ORCID: https://orcid.org/0000-0002-7142-1158, Makia, Christine, Kouokam Magne, Estelle, Nnamdi, Dum-Buo, Mue Nji, Theobald, Ntuen, Uduak, Oluwole, Akinola, Piotrowski, Helen, Siping, Marlene, Tchoffo, Marlene Ntsinda, Tchuem Tchuenté, Louis-Albert, Thomson, Rachael, Tsey, Irene, Wanji, Samuel, Yashiyi, James, Zawolo, Georgina and Theobald, Sally ORCID: https://orcid.org/0000-0002-9053-211X (2019) 'Neglected Tropical Diseases as a ‘litmus test’ for Universal Health Coverage? Understanding who is left behind and why in Mass Drug Administration: Lessons from four country contexts'. PLoS Neglected Tropical Diseases, Vol 13, Issue 11, e0007847.
|
Text
journal.pntd.0007847.pdf - Published Version Available under License Creative Commons Attribution. Download (945kB) | Preview |
Abstract
Individuals and communities affected by NTDs are often the poorest and most marginalised; ensuring a gender and equity lens is centre stage will be critical for the NTD community to reach elimination goals and inform Universal Health Coverage (UHC). NTDs amenable to preventive chemotherapy have been described as a ‘litmus test’ for UHC due to the high mass drug administration (MDA) coverage rates needed to be effective and their model of community engagement. However, until now highly aggregated coverage data may have
masked inequities in availability, accessibility and acceptability of medicines, slowing down the equitable achievement of elimination goals.
Statistics
Actions (login required)
Edit Item |